When you have early-stage cancer, the 'cancer markers' in your blood aren't actually coming from the tumor—they’re coming from your healthy tissue.
April 17, 2026
Original Paper
Early-stage cancer results in a multiplicative increase in cell-free DNA originating from healthy tissue
bioRxiv · 2024.01.26.577500
AI-generated illustration
The Takeaway
Most people assume that 'liquid biopsies' for cancer work by finding DNA shed by the tumor itself. However, this study found that in early stages, the massive spike in DNA in the blood actually comes from healthy tissues. It happens because the tumor causes the body's DNA 'cleanup crew' to get overwhelmed and 'clog up,' allowing normal DNA to pile up in the bloodstream. This is a total surprise because it means we've been misinterpreting the source of our most important diagnostic signals. Knowing that this signal is a 'traffic jam' in the body rather than a direct message from the tumor could help us detect cancer much earlier than ever before.
From the abstract
Cell-free DNA is a promising biomarker for cancer detection. However, the sources of elevated cell-free DNA (cfDNA) in patients with early-stage cancer, and the mechanisms by which cfDNA is shed into, and subsequently cleared from the circulation are still poorly understood. Leveraging a rich dataset of cfDNA in healthy individuals and early-stage cancer patients, we find a multiplicative increase in cfDNA concentration in the presence of cancer. This increase is cancer type-specific, ranging fr